The reiterated full-year outlook and 6% order intake growth suggest steady execution, but macro headwinds (tariffs, cost inflation) are pressuring margins. Monitor upcoming quarters for margin trajectory and any guidance revision given the uncertain tariff environment.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 6 $27.23entry
- T+1 · 6mo ago −4.00%α −3.69% · $26.14
- T+5 · 6mo ago −5.88%α −7.03% · $25.63
- T+20 · 6mo ago −4.55%α −7.72% · $25.99
- T+60 · 4mo ago −3.67%α −7.19% · $26.23
Price Chart
How similar events traded
Executive Summary
Royal Philips reported Q1 2026 comparable sales growth of 4% to EUR 3.9 billion and adjusted EBITA margin expansion of 40 bps to 9.0%, with income from operations of EUR 241 million. The company reiterated its full-year 2026 outlook for 3%-4.5% comparable sales growth and 12.5%-13.0% adjusted EBITA margin. The EPS consensus of $0.19 per ADS is not directly comparable to the reported EUR-denominated per-share figures, so no EPS surprise is computed.
Key Financial Metrics
Key Facts
- Q1 2026 comparable sales growth of 4% to EUR 3.9 billion
- Adjusted EBITA margin expanded 40 bps to 9.0%
- Comparable order intake grew 6%
- Income from operations increased to EUR 241 million
- Free cash flow of EUR 28 million
- Full-year 2026 outlook reiterated: comparable sales growth 3%-4.5%, adjusted EBITA margin 12.5%-13.0%, free cash flow EUR 1.3-1.5 billion
- EUR 126 million in productivity savings in the quarter
- Share repurchase of up to 4 million shares (approx. EUR 91 million) for long-term incentive plans
Financial Impact
Q1 sales EUR 3.9B, income from operations EUR 241M, free cash flow EUR 28M; full-year outlook implies EUR 18.5-18.7B sales at midpoint
Segment Breakdown
| Segment | Growth |
|---|---|
| Diagnosis & Treatment | +2.0% |
| Connected Care | +3.0% |
| Personal Health | +9.0% |
Risk Factors
- Higher tariffs and cost inflation impacting margins, especially in Connected Care (margin down 60 bps)
- Ongoing Philips Respironics-related proceedings and DOJ investigation excluded from outlook
- Uncertain macro environment with potential IEEPA tariff refunds excluded from guidance
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3288473 |
Track record
12 reports on PHG
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 3, 202613d ago 6-K Neutral 5/10 No price data
- Nov 3, 202614d ago Press Release Neutral 5/10 Entry $28.46 Now $30.14 +5.90% settles Feb 1
- Oct 29, 202618d ago Press Release Neutral 3/10 Entry $27.12 Now $30.14 +11.14% settles Jan 27
- Aug 27, 202611w ago Press Release Neutral 3/10 Entry $26.92 Now $30.14 +11.96% settles Nov 20
- Aug 24, 202612w ago Press Release Neutral 3/10 Entry $27.43 Now $30.14 +9.88% settles Nov 18
- Jul 27, 202616w ago Press Release Mixed 6/10 Entry $25.02 to $26.00 Now $30.14 +20.46% ▲ +3.92% −0.14% vs SPY
- Jun 2, 202623w ago Press Release Neutral 2/10 Entry $25.43 to $26.99 Now $30.14 +18.52% ▲ +6.13% +5.02% vs SPY
- May 15, 202626w ago Court Ruling Bullish 4/10 Entry $26.05 to $27.38 Now $30.14 +15.70% ▲ +5.11% −0.48% vs SPY
- May 6, 202627w ago Press Release Neutral 4/10 Viewing Entry $27.23 to $26.23 Now $30.14 +10.69% ▼ −3.67% −7.19% vs SPY
- Mar 23, 202634w ago Press Release Neutral 3/10 Entry $26.81 to $26.24 Now $30.14 +12.42% ▼ −2.13% −15.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers